Closeness to Death and Quality of Life in Advanced Lung Cancer Patients

Clinical Oncology

Volumn 19, Issue 5, 2007, Pages 341-348

  Brown, S ^a   Thorpe, H ^a   Napp, V ^a   Brown, J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Advanced lung cancer; closeness to death; quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FACTORIAL ANALYSIS; FEMALE; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT INFORMATION; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE INDEX; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; UNIVARIATE ANALYSIS;

ACTIVITIES OF DAILY LIVING; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DEATH; FEMALE; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; TIME FACTORS;

EID: 34248591512     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.02.008     Document Type: Article

References (10)

1. Sarna L., and Riedinger M.S. Assessment of quality of life and symptom improvement in lung cancer clinical trials. Semin Oncol 31 Suppl 9 (2004) 1-10
2. Morita S., Kobayashi K., Eguchi K., et al. Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: application of a general linear model. Jpn J Clin Oncol 33 (2003) 470-476
3. Coates A., Portszolt F., and Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 33 (1997) 1025-1030
4. Jordhoy M.S., Fayers P., Loge J.H., Saltnes T., Ahlner-Elmqvist M., and Kaasa S. Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer 85 (2001) 1478-1485
5. Brown J., Thorpe H., Napp V., et al. Assessment of quality of life in the supportive care setting of the Big Lung Trial in non-small cell lung cancer. J Clin Oncol 23 (2005) 7417-7427
6. Aaronson N.K., Ahmedzai S.A., Bergman B., et al. for the European Organization for Research and Treatment of Cancer Study Group on Quality of Life. The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
7. Fayers P., Aaronson N., Bjordal K., Sullivan M., and on behalf of the EORTC Quality of Life Study Group. EORTC QLQ-C30 scoring manual (1995), EORTC Study Group on Quality of Life, Brussels
8. Osoba D., Rodrigues G., Myles J., Zee B., and Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16 (1998) 139-144
9. ICH E9 Expert Working Group ICH harmonised tripartite guideline: statistical principles for clinical trials. Stat Med 1999;18:1905-1942.
10. King M.T. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 5 (1996) 555-567